Edmarie Guzman-Velez, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Presenilin-1 | 15 | 2024 | 665 | 2.270 |
Why?
|
| Alzheimer Disease | 23 | 2024 | 8730 | 1.420 |
Why?
|
| Neurofilament Proteins | 2 | 2021 | 337 | 0.750 |
Why?
|
| Neuropsychological Tests | 13 | 2024 | 7123 | 0.720 |
Why?
|
| Mental Recall | 2 | 2020 | 1218 | 0.550 |
Why?
|
| Memory | 3 | 2020 | 2190 | 0.510 |
Why?
|
| Emotions | 3 | 2020 | 2763 | 0.490 |
Why?
|
| Colombia | 9 | 2024 | 287 | 0.460 |
Why?
|
| Cognitive Reserve | 1 | 2014 | 92 | 0.430 |
Why?
|
| Multilingualism | 1 | 2014 | 86 | 0.430 |
Why?
|
| Hippocampus | 2 | 2015 | 3775 | 0.400 |
Why?
|
| Brain | 8 | 2021 | 27171 | 0.370 |
Why?
|
| Memory Disorders | 2 | 2019 | 1194 | 0.370 |
Why?
|
| Mutation | 9 | 2024 | 30198 | 0.360 |
Why?
|
| Amygdala | 1 | 2015 | 1377 | 0.290 |
Why?
|
| Emigrants and Immigrants | 1 | 2014 | 549 | 0.290 |
Why?
|
| tau Proteins | 5 | 2021 | 2112 | 0.280 |
Why?
|
| Amyloid beta-Peptides | 7 | 2021 | 3896 | 0.270 |
Why?
|
| Positron-Emission Tomography | 10 | 2021 | 6547 | 0.260 |
Why?
|
| Amyloid | 3 | 2019 | 853 | 0.240 |
Why?
|
| Heterozygote | 3 | 2021 | 2794 | 0.230 |
Why?
|
| Aniline Compounds | 3 | 2021 | 1075 | 0.180 |
Why?
|
| Dementia, Vascular | 1 | 2021 | 126 | 0.170 |
Why?
|
| Apolipoprotein E3 | 1 | 2019 | 105 | 0.160 |
Why?
|
| Happiness | 2 | 2020 | 173 | 0.140 |
Why?
|
| Cross-Sectional Studies | 8 | 2021 | 26318 | 0.140 |
Why?
|
| Music | 1 | 2020 | 249 | 0.140 |
Why?
|
| Plaque, Amyloid | 1 | 2021 | 772 | 0.140 |
Why?
|
| Tauopathies | 1 | 2019 | 325 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 1 | 2018 | 999 | 0.120 |
Why?
|
| Cognition | 4 | 2024 | 7049 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 2 | 2020 | 1087 | 0.110 |
Why?
|
| Language | 2 | 2014 | 1550 | 0.110 |
Why?
|
| Corpus Striatum | 1 | 2019 | 1218 | 0.100 |
Why?
|
| Male | 18 | 2021 | 363698 | 0.090 |
Why?
|
| Adult | 13 | 2021 | 223044 | 0.090 |
Why?
|
| Female | 18 | 2021 | 396112 | 0.090 |
Why?
|
| Organ Size | 1 | 2015 | 2260 | 0.090 |
Why?
|
| Translating | 1 | 2011 | 144 | 0.090 |
Why?
|
| Video Recording | 1 | 2015 | 969 | 0.090 |
Why?
|
| Pattern Recognition, Automated | 1 | 2015 | 978 | 0.080 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 1881 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2020 | 2643 | 0.080 |
Why?
|
| Humans | 24 | 2024 | 765968 | 0.080 |
Why?
|
| Executive Function | 1 | 2018 | 1391 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 18071 | 0.080 |
Why?
|
| Middle Aged | 12 | 2021 | 223009 | 0.080 |
Why?
|
| Communication Barriers | 1 | 2011 | 418 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 36532 | 0.070 |
Why?
|
| Young Adult | 6 | 2020 | 59889 | 0.070 |
Why?
|
| Self Report | 2 | 2019 | 3770 | 0.070 |
Why?
|
| Age of Onset | 1 | 2014 | 3344 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 14751 | 0.070 |
Why?
|
| Educational Status | 1 | 2014 | 2513 | 0.070 |
Why?
|
| Genotype | 1 | 2021 | 13024 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2019 | 5125 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2015 | 6322 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 59489 | 0.060 |
Why?
|
| Personality Tests | 1 | 2021 | 80 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2020 | 22223 | 0.050 |
Why?
|
| Aged | 6 | 2020 | 171117 | 0.040 |
Why?
|
| Intermediate Filaments | 1 | 2020 | 171 | 0.040 |
Why?
|
| Dementia | 1 | 2014 | 2744 | 0.040 |
Why?
|
| Apolipoprotein E2 | 1 | 2019 | 133 | 0.040 |
Why?
|
| Latin America | 1 | 2020 | 416 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 8923 | 0.040 |
Why?
|
| Adolescent | 4 | 2020 | 88835 | 0.040 |
Why?
|
| Ethylene Glycols | 1 | 2019 | 196 | 0.040 |
Why?
|
| Carbolines | 1 | 2018 | 288 | 0.030 |
Why?
|
| Preventive Health Services | 1 | 2021 | 570 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1187 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2019 | 586 | 0.030 |
Why?
|
| Homozygote | 1 | 2019 | 1775 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2021 | 1123 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 39193 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2020 | 1003 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1145 | 0.030 |
Why?
|
| Time Factors | 1 | 2014 | 40065 | 0.030 |
Why?
|
| Reference Values | 1 | 2019 | 4908 | 0.020 |
Why?
|
| Pedigree | 1 | 2019 | 4526 | 0.020 |
Why?
|
| Thiazoles | 1 | 2018 | 1529 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2011 | 504 | 0.020 |
Why?
|
| Family | 1 | 2021 | 3209 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2019 | 2699 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 2410 | 0.020 |
Why?
|
| Boston | 1 | 2021 | 9338 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2021 | 41649 | 0.020 |
Why?
|
| Sex Factors | 1 | 2021 | 10603 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2018 | 3967 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2019 | 6273 | 0.010 |
Why?
|
| Registries | 1 | 2019 | 8297 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13632 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18380 | 0.010 |
Why?
|
| Child | 2 | 2020 | 80564 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 16047 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 81514 | 0.010 |
Why?
|
| Risk Factors | 1 | 2021 | 74840 | 0.010 |
Why?
|